Received Apr 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLUARIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | NG5FM | IM / RA |
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 1 | T5D73 | IM / LA |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 1 | Y004114 | SC / LA |
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 3RE73 | IM / RA |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 1 | Y017062 | SC / RA |
Client experienced a 10 second episode of decrease responsiveness, pallor and diaphoresis 3 minutes after receiving vaccine. Vital signs remained stable.
None
None
None
NKA